228 related articles for article (PubMed ID: 28634180)
21. A plausible role for actin gamma smooth muscle 2 (ACTG2) in small intestinal neuroendocrine tumorigenesis.
Edfeldt K; Hellman P; Westin G; Stalberg P
BMC Endocr Disord; 2016 Apr; 16():19. PubMed ID: 27107594
[TBL] [Abstract][Full Text] [Related]
22. Driver mutations occur frequently in metastases of well-differentiated small intestine neuroendocrine tumours.
Samsom KG; Levy S; van Veenendaal LM; Roepman P; Kodach LL; Steeghs N; Valk GD; Wouter Dercksen M; Kuhlmann KFD; Verbeek WHM; Meijer GA; Tesselaar MET; van den Berg JG
Histopathology; 2021 Mar; 78(4):556-566. PubMed ID: 32931025
[TBL] [Abstract][Full Text] [Related]
23. Association of a New Germline Variant in the MUTYH DNA Glycosylase Gene with Colorectal Adenoma Transformation into Malignancy.
Mahasneh A; Al-Shaheri FN; BaniHani MN
Iran Biomed J; 2019 Nov; 23(6):412-22. PubMed ID: 31104418
[TBL] [Abstract][Full Text] [Related]
24. Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors.
Park C; Ha SY; Kim ST; Kim HC; Heo JS; Park YS; Lauwers G; Lee J; Kim KM
Oncotarget; 2016 Jan; 7(4):4024-35. PubMed ID: 26684240
[TBL] [Abstract][Full Text] [Related]
25. Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis.
Nielsen M; Hes FJ; Nagengast FM; Weiss MM; Mathus-Vliegen EM; Morreau H; Breuning MH; Wijnen JT; Tops CM; Vasen HF
Clin Genet; 2007 May; 71(5):427-33. PubMed ID: 17489848
[TBL] [Abstract][Full Text] [Related]
26. Loss of expression of DNA mismatch repair proteins is rare in pancreatic and small intestinal neuroendocrine tumors.
Arnason T; Sapp HL; Rayson D; Barnes PJ; Drewniak M; Nassar BA; Huang WY
Arch Pathol Lab Med; 2011 Dec; 135(12):1539-44. PubMed ID: 22129180
[TBL] [Abstract][Full Text] [Related]
27. A Hereditary Form of Small Intestinal Carcinoid Associated With a Germline Mutation in Inositol Polyphosphate Multikinase.
Sei Y; Zhao X; Forbes J; Szymczak S; Li Q; Trivedi A; Voellinger M; Joy G; Feng J; Whatley M; Jones MS; Harper UL; Marx SJ; Venkatesan AM; Chandrasekharappa SC; Raffeld M; Quezado MM; Louie A; Chen CC; Lim RM; Agarwala R; Schäffer AA; Hughes MS; Bailey-Wilson JE; Wank SA
Gastroenterology; 2015 Jul; 149(1):67-78. PubMed ID: 25865046
[TBL] [Abstract][Full Text] [Related]
28. Somatic Mutations and Genetic Heterogeneity at the CDKN1B Locus in Small Intestinal Neuroendocrine Tumors.
Crona J; Gustavsson T; Norlén O; Edfeldt K; Åkerström T; Westin G; Hellman P; Björklund P; Stålberg P
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1428-35. PubMed ID: 25586243
[TBL] [Abstract][Full Text] [Related]
29. MUTYH hotspot mutations in unselected colonoscopy patients.
Casper M; Plotz G; Juengling B; Zeuzem S; Lammert F; Raedle J
Colorectal Dis; 2012 May; 14(5):e238-44. PubMed ID: 22469480
[TBL] [Abstract][Full Text] [Related]
30. [From gene to disease; MutYH-associated polyposis coli (MAP)].
Nielsen M; Weiss MM; Vasen HF; Hes FJ
Ned Tijdschr Geneeskd; 2005 Dec; 149(53):2970-2. PubMed ID: 16425850
[TBL] [Abstract][Full Text] [Related]
31. Somatic mutation of CDKN1B in small intestine neuroendocrine tumors.
Francis JM; Kiezun A; Ramos AH; Serra S; Pedamallu CS; Qian ZR; Banck MS; Kanwar R; Kulkarni AA; Karpathakis A; Manzo V; Contractor T; Philips J; Nickerson E; Pho N; Hooshmand SM; Brais LK; Lawrence MS; Pugh T; McKenna A; Sivachenko A; Cibulskis K; Carter SL; Ojesina AI; Freeman S; Jones RT; Voet D; Saksena G; Auclair D; Onofrio R; Shefler E; Sougnez C; Grimsby J; Green L; Lennon N; Meyer T; Caplin M; Chung DC; Beutler AS; Ogino S; Thirlwell C; Shivdasani R; Asa SL; Harris CR; Getz G; Kulke M; Meyerson M
Nat Genet; 2013 Dec; 45(12):1483-6. PubMed ID: 24185511
[TBL] [Abstract][Full Text] [Related]
32. The natural history of a combined defect in MSH6 and MUTYH in a HNPCC family.
van Puijenbroek M; Nielsen M; Reinards TH; Weiss MM; Wagner A; Hendriks YM; Vasen HF; Tops CM; Wijnen J; van Wezel T; Hes FJ; Morreau H
Fam Cancer; 2007; 6(1):43-51. PubMed ID: 17039270
[TBL] [Abstract][Full Text] [Related]
33. Identification of patients with (atypical) MUTYH-associated polyposis by KRAS2 c.34G > T prescreening followed by MUTYH hotspot analysis in formalin-fixed paraffin-embedded tissue.
van Puijenbroek M; Nielsen M; Tops CM; Halfwerk H; Vasen HF; Weiss MM; van Wezel T; Hes FJ; Morreau H
Clin Cancer Res; 2008 Jan; 14(1):139-42. PubMed ID: 18172263
[TBL] [Abstract][Full Text] [Related]
34. Mutational analysis of OGG1, MYH, MTH1 in FAP, HNPCC and sporadic colorectal cancer patients: R154H OGG1 polymorphism is associated with sporadic colorectal cancer patients.
Kim IJ; Ku JL; Kang HC; Park JH; Yoon KA; Shin Y; Park HW; Jang SG; Lim SK; Han SY; Shin YK; Lee MR; Jeong SY; Shin HR; Lee JS; Kim WH; Park JG
Hum Genet; 2004 Nov; 115(6):498-503. PubMed ID: 15449173
[TBL] [Abstract][Full Text] [Related]
35. Increased MUTYH mutation frequency among Dutch families with breast cancer and colorectal cancer.
Wasielewski M; Out AA; Vermeulen J; Nielsen M; van den Ouweland A; Tops CM; Wijnen JT; Vasen HF; Weiss MM; Klijn JG; Devilee P; Hes FJ; Schutte M
Breast Cancer Res Treat; 2010 Dec; 124(3):635-41. PubMed ID: 20191381
[TBL] [Abstract][Full Text] [Related]
36. Germline hypermethylation of the APC promoter is not a frequent cause of familial adenomatous polyposis in APC/MUTYH mutation negative families.
Romero-Giménez J; Dopeso H; Blanco I; Guerra-Moreno A; Gonzalez S; Vogt S; Aretz S; Schwartz S; Capella G; Arango D
Int J Cancer; 2008 Mar; 122(6):1422-5. PubMed ID: 18027849
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of germline MUTYH mutations among Lynch-like syndrome patients.
Castillejo A; Vargas G; Castillejo MI; Navarro M; Barberá VM; González S; Hernández-Illán E; Brunet J; Ramón y Cajal T; Balmaña J; Oltra S; Iglesias S; Velasco A; Solanes A; Campos O; Sánchez Heras AB; Gallego J; Carrasco E; González Juan D; Segura A; Chirivella I; Juan MJ; Tena I; Lázaro C; Blanco I; Pineda M; Capellá G; Soto JL
Eur J Cancer; 2014 Sep; 50(13):2241-50. PubMed ID: 24953332
[TBL] [Abstract][Full Text] [Related]
38. TCEB3C a putative tumor suppressor gene of small intestinal neuroendocrine tumors.
Edfeldt K; Ahmad T; Åkerström G; Janson ET; Hellman P; Stålberg P; Björklund P; Westin G
Endocr Relat Cancer; 2014 Apr; 21(2):275-84. PubMed ID: 24351681
[TBL] [Abstract][Full Text] [Related]
39. Base excision repair deficiency signatures implicate germline and somatic
Thibodeau ML; Zhao EY; Reisle C; Ch'ng C; Wong HL; Shen Y; Jones MR; Lim HJ; Young S; Cremin C; Pleasance E; Zhang W; Holt R; Eirew P; Karasinska J; Kalloger SE; Taylor G; Majounie E; Bonakdar M; Zong Z; Bleile D; Chiu R; Birol I; Gelmon K; Lohrisch C; Mungall KL; Mungall AJ; Moore R; Ma YP; Fok A; Yip S; Karsan A; Huntsman D; Schaeffer DF; Laskin J; Marra MA; Renouf DJ; Jones SJM; Schrader KA
Cold Spring Harb Mol Case Stud; 2019 Apr; 5(2):. PubMed ID: 30833417
[TBL] [Abstract][Full Text] [Related]
40. Mutagenesis and carcinogenesis caused by the oxidation of nucleic acids.
Nakabeppu Y; Sakumi K; Sakamoto K; Tsuchimoto D; Tsuzuki T; Nakatsu Y
Biol Chem; 2006 Apr; 387(4):373-9. PubMed ID: 16606334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]